Patent details

EP2416774 Title: TREATMENT REGIMEN UTILIZING NERATINIB FOR BREAST CANCER

  • Data
  • Documents

Basic Information

Publication number:
EP2416774
PCT Application Number:
PCT/US/2010/028448
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP107222150
PCT Publication Number:
WO/2010/117633
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TREATMENT REGIMEN UTILIZING NERATINIB FOR BREAST CANCER
French Title of Invention:
RÉGIME DE TRAITEMENT À L'AIDE DE NÉRATINIB POUR UN CANCER DU SEIN
German Title of Invention:
BEHANDLUNGSSCHEMA MIT NERATINIB GEGEN BRUSTKREBS
SPC Number:

Dates

Filing date:
24/03/2010
Grant date:
04/11/2015
EP Publication Date:
04/11/2015
PCT Publication Date:
14/10/2010
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
15/02/2012
EP B1 Publication Date:
04/11/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
24/03/2016
Expiration date:
24/03/2030
Renunciation date:
Revocation date:
02/09/2021
Annulment date:

Owner

From:
24/03/2010
 
 

Name:
Wyeth LLC
Address:
235 East 42nd Street, New York, NY 10017, United States (US)

Inventor

1

Name:
BERKENBLIT Anna
Address:
United States (US)

2

Name:
BINLICH Florence
Address:
France (FR)

3

Name:
GOSS Paul
Address:
United States (US)

Priority

Priority Number:
166796 P
Priority Date:
06/04/2009
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/4709;

Publication

European Patent Bulletin

Issue number:
202202
Publication date:
12/01/2022
Description:
Revocation of the European patent
Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer: